603986:SSEGiga Device Semiconductor Inc. Class A Analysis
Data as of 2026-05-28 - not real-time
CN¥483.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
GigaDevice is trading at CNY 483, comfortably above its 20‑day (CNY 398), 50‑day (CNY 326) and 200‑day (CNY 244) moving averages, and the MACD line sits well above its signal line, signaling a strong bullish momentum. The RSI of 69 suggests the stock is approaching overbought territory but has not yet crossed the critical 70 threshold, while volume is on an increasing trend, reinforcing the technical upside. Fundamentally, the company posts an impressive 119% revenue growth and a robust operating margin of 41%, backed by a massive cash pile of CNY 15.1 bn and minimal debt, indicating solid financial health. However, valuation metrics are starkly misaligned: a trailing P/E of 112 dwarfs the industry average of 41, and the DCF‑derived fair value of just CNY 82 is a fraction of the current price, flagging severe overvaluation. The dividend yield is modest at 0.16% with a low payout ratio, making the dividend sustainable but not a primary attraction. High 30‑day volatility (≈71%) and a max drawdown of –27% add a layer of price risk, though beta around 0.85 points to lower systematic market sensitivity. In summary, the stock’s technicals are bullish, its fundamentals strong, but the price appears dramatically stretched, warranting a cautious stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical setup (price above SMAs, bullish MACD)
- Severe overvaluation relative to DCF and industry PE
- Elevated short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth and high operating margins
- Continued cash generation and low debt
- Persistently high valuation multiples limiting upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Robust growth trajectory in semiconductor demand
- Solid balance sheet with ample cash and low leverage
- Potential for valuation correction aligning price with intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth119.40%
Profit Margin25.04%
P/E Ratio111.8
ROE13.69%
ROA7.79%
Debt/Equity0.38
P/B Ratio13.4
Op. Cash FlowCN¥3.6B
Free Cash FlowCN¥1.2B
Industry P/E40.9
Technical Analysis
TrendBullish
RSI69.4
SupportCN¥297.00
ResistanceCN¥552.82
MA 20CN¥397.97
MA 50CN¥325.75
MA 200CN¥243.77
MACDBullish
VolumeIncreasing
Fear & Greed Index93.32
Valuation
Fair ValueCN¥82.27
GradeOvervalued
TypeGrowth
Dividend Yield0.16%
Risk Assessment
Beta0.85
Volatility70.92%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.